AtriCure, Inc. (ATRC) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Atricure, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.795 Good afternoon, and welcome to AtriCure's fourth quarter and full year 2025 earnings 00:00:04.795 -- 00:00:09.880 conference call. This call is being recorded for replay purposes, and at this 00:00:09.880 -- 00:00:13.683 time, all participants are in listen-only mode. 00:00:13.683 -- 00:00:18.688 We will be facilitating a question and answer session following prepared remarks from 00:00:18.688 -- 00:00:24.053 AtriCure's management. I would now like to turn the call over to Marissa Beitsch 00:00:24.053 -- 00:00:28.715 from the Gilmartin Group for a few introductory comments. 00:00:29.317 -- 00:00:34.364 Great, thank you. By now, you should have received a copy of the earnings press release. 00:00:34.364 -- 00:00:38.068 If you have not received a copy, please call 513-644-4484 00:00:38.068 -- 00:00:40.010 to 00:00:40.010 -- 00:00:45.036 have one emailed to you. Before we begin today, let me remind you 00:00:45.036 -- 00:00:48.520 that the company's remarks include forward-looking statements. 00:00:48.520 -- 00:00:53.166 Forward-looking statements are subject to numerous risks and uncertainties, many of which 00:00:53.166 -- 00:00:57.471 are beyond HRCARE's control, including risks and uncertainties described from time to 00:00:57.471 -- 00:01:02.674 time in HRCARE's SEC filings. These statements include, but are not limited 00:01:02.674 -- 00:01:07.881 to, financial expectations and guidance, expectations regarding the potential market 00:01:07.881 -- 00:01:13.207 opportunity for Atricure's franchises and growth initiatives, future product approvals 00:01:13.207 -- 00:01:19.435 and clearances, competition, reimbursement, and clinical trial outcomes. 00:01:19.435 -- 00:01:23.800 Atricure's results may differ materially from those proj...